Boothbay Fund Management, LLC X4 Pharmaceuticals, Inc Transaction History

Boothbay Fund Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.69 - $2.21 $15,650 - $50,127	-22,682 Reduced 38.6%	36,078 $35,000
Q3 2022 Nov 14, 2022	SELL	$0.89 - $1.71 $107,870 - $207,257	-121,203 Reduced 67.35%	58,760 $100,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.91 $34,320 - $74,490	39,000 Added 27.67%	179,963 $174,000
Q1 2022 May 16, 2022	SELL	$1.48 - $2.58 $144,452 - $251,815	-97,603 Reduced 40.91%	140,963 $247,000
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $55,130 - $162,489	-29,016 Reduced 10.84%	238,566 $546,000
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $274,640 - $391,044	-60,627 Reduced 18.47%	267,582 $1.42 Million
Q2 2021 Aug 16, 2021	BUY	$6.49 - $9.56 $127,515 - $187,834	19,648 Added 6.37%	328,209 $2.13 Million
Q1 2021 May 17, 2021	BUY	$6.63 - $10.28 $1.47 Million - $2.27 Million	221,197 Added 253.19%	308,561 $2.66 Million
Q4 2020 Feb 12, 2021	BUY	$5.41 - $7.4 $57,340 - $78,432	10,599 Added 13.81%	87,364 $562,000
Q3 2020 Nov 16, 2020	BUY	$6.09 - $9.15 $467,498 - $702,399	76,765 New	76,765 $520,000
Q1 2020 May 15, 2020	SELL	$6.03 - $11.01 $95,515 - $174,398	-15,840 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.93 - $14.33 $157,291 - $226,987	15,840 New	15,840 $169,000

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $41.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.